FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Califf Testifies on Accelerated Approvals

[ Price : $8.95]

FDA commissioner Robert Califf tells a Senate appropriations hearing that FDA and CMS are working to make sure clinical trials for...

DBV Tech Gets FDA Input in pre-BLA Meeting

[ Price : $8.95]

DBV Technologies receives written responses from FDA after a pre-BLA meeting in February about the regulatory path for investigati...

BelGene Gastric Cancer Drug Trial Hits Primary Endpoint

[ Price : $8.95]

BelGene says its tislelizumab with chemotherapy met the primary endpoint of overall survival in patients with some gastric cancers...

CGMP Violations at Zermat International

[ Price : $8.95]

FDA warns Tlalnepantla, Mexico-based Zermat International about repeat CGMP violations in its manufacturing of over-the-counter dr...

Fresenius Kabi Recalls Ivenix Infusion Device

[ Price : $8.95]

Fresenius Kabi recalls its Ivenix Infusion System due to a leak in the device that allows fluid to enter the administration set lo...

Info Collection on Rapid Response Surveys

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Rapid Response Surveys.

2 EUAs for Ebola Tests Withdrawn

[ Price : $8.95]

Federal Register notice: FDA revokes the emergency use authorizations issued to BioFire Defense for the FilmArray NGDS BT‐E ...

North American Diagnostics Illegal Covid Tests

[ Price : $8.95]

FDA warns Holly Hill, FL-based North American Diagnostics it is illegally manufacturing and distributing adulterated and misbrande...

Radiation Syndrome Drug Development Guidance

[ Price : $8.95]

FDA publishes a draft guidance with information and recommendations to assist in developing drugs to prevent or treat acute radiat...

NCI Sees Revumenib Promise for Some Leukemias

[ Price : $8.95]

The National Cancer Institute says Syndax Pharmaceuticals revumenib shows promise in treating some acute myeloid leukemias.